Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In persons with type 1 diabetes and high glycated hemoglobin levels, the benefits of intermittently scanned continuous glucose monitoring with optional alarms for high and low blood glucose levels are uncertain. METHODS: In a parallel-group, multicenter, randomized, controlled trial involving participants with type 1 diabetes and glycated hemoglobin levels between 7.5% and 11.0%, we investigated the efficacy of intermittently scanned continuous glucose monitoring as compared with participant monitoring of blood glucose levels with fingerstick testing. The primary outcome was the glycated hemoglobin level at 24 weeks, analyzed according to the intention-to-treat principle. Key secondary outcomes included sensor data, participant-reported outcome measures, and safety. RESULTS: A total of 156 participants were randomly assigned, in a 1:1 ratio, to undergo intermittently scanned continuous glucose monitoring (the intervention group, 78 participants) or to monitor their own blood glucose levels with fingerstick testing (the usual-care group, 78 participants). At baseline, the mean (±SD) age of the participants was 44±15 years, and the mean duration of diabetes was 21±13 years; 44% of the participants were women. The mean baseline glycated hemoglobin level was 8.7±0.9% in the intervention group and 8.5±0.8% in the usual-care group; these levels decreased to 7.9±0.8% and 8.3±0.9%, respectively, at 24 weeks (adjusted mean between-group difference, -0.5 percentage points; 95% confidence interval [CI], -0.7 to -0.3; P<0.001). The time per day that the glucose level was in the target range was 9.0 percentage points (95% CI, 4.7 to 13.3) higher or 130 minutes (95% CI, 68 to 192) longer in the intervention group than in the usual-care group, and the time spent in a hypoglycemic state (blood glucose level, <70 mg per deciliter [<3.9 mmol per liter]) was 3.0 percentage points (95% CI, 1.4 to 4.5) lower or 43 minutes (95% CI, 20 to 65) shorter in the intervention group. Two participants in the usual-care group had an episode of severe hypoglycemia, and 1 participant in the intervention group had a skin reaction to the sensor. CONCLUSIONS: Among participants with type 1 diabetes and high glycated hemoglobin levels, the use of intermittently scanned continuous glucose monitoring with optional alarms for high and low blood glucose levels resulted in significantly lower glycated hemoglobin levels than levels monitored by fingerstick testing. (Funded by Diabetes UK and others; FLASH-UK ClinicalTrials.gov number, NCT03815006.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., Maahs, D. M., Tamborlane, W. V., Bergenstal, R., Smith, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0384 · Cited by 1,907
Assessing Psychosocial Distress in Diabetes
Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.626 · Cited by 1,575
Gilbody, S., Richards, D., Brealey, S., & Hewitt, C. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0333-y · Cited by 1,290
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
Daneman, D. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68341-4 · Cited by 921
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Schwarz, E., Ólafsdóttir, A. F., Frid, A., Wedel, H., et al. (2017) · JAMA · doi:10.1001/jama.2016.19976 · Cited by 705
Reddy, M., Jugnee, N., El Laboudi, A., Spanudakis, E., Anantharaja, S., & Oliver, N. (2018) · Diabetic Medicine · doi:10.1111/dme.13561 · Cited by 245
Cro, S., Morris, T. P., Kenward, M. G., & Carpenter, J. R. (2020) · Statistics in Medicine · doi:10.1002/sim.8569 · Cited by 203
Cited by
Items 101–182 of 182
Navas-Moreno, V., Sebastián‐Valles, F., Sampedro-Nuñez, M. A., Vargas, M. L., Marazuela, M., & Martín, J. A. A. (2023) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2023.06.005 · Cited by 3
Sehgal, S., Elbalshy, M. M., Williman, J. A., Galland, B. C., Crocket, H. R., Hall, R. M., Paul, R. G., Leikis, R., de Bock, M. I., & Wheeler, B. J. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231196562 · Cited by 3
Hachem, M., Hearn, T., Kelly, R. D., Eer, A., Moore, B., Sommerville, C., Atkinson‐Briggs, S., Twigg, S. M., Freund, M., O'Neal, D. N., et al. (2024) · Trials · doi:10.1186/s13063-024-08267-7 · Cited by 4
Introduction to emerging biosensing technologies
Shukla, M., Mahato, K., & Pandya, A. (2025) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2025.05.013 · Cited by 3
Private Sector Provision as an “Escape Valve”: The Mexico Diabetes Experiment
Bronsoler, A., B, J. G. A., & Seira, E. (2021) · The Review of Economic Studies · doi:10.1093/restud/rdae024 · Cited by 4
Zooming In, Then Out: Why We Must Apply Human-Centered Design to Transform Diabetes Technology
Chao, E. C. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231213665 · Cited by 3
Assessing the Financial Sustainability of a Virtual Clinic Providing Comprehensive Diabetes Care
Dupenloup, P., Guan, G., Aleppo, G., Bergenstal, R. M., Hood, K. K., Kruger, D. F., MCARTHUR, T. S., Olson, B. A., Oser, S. M., Oser, T. K., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251340664 · Cited by 2
Qin, L.-J., Ma, W., Cui, S., Du, Y., Lian, L.-L., & Jin, M.-M. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.113022 · Cited by 2
Sugai, K., Sasaki, J., Tomizawa, G., & Suzuki, R. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70233 · Cited by 2
Environmental sustainability considerations in the reporting of randomised clinical trials
van Royen, F. S.-A., & Schuit, E. (2026) · The Lancet Planetary Health · doi:10.1016/j.lanplh.2025.101412 · Cited by 3
Pazos-Couselo, M., Izquierdo, V., Martínez, M. M., Romero, F. J. G., Muñoz‐Rodríguez, J. R., Fernández‐Pombo, A., & Moreno-Fernández, J. (2026) · Worldviews on Evidence-Based Nursing · doi:10.1111/wvn.70139 · Cited by 2
Chen, X., Kim, G. E., Kim, N. A., & Kim, K. J. (2026) · Healthcare · doi:10.3390/healthcare14081019 · Cited by 3
Continuous glucose monitoring for type 1 diabetes
Gordon, C. (2023) · Practice Nursing · doi:10.12968/pnur.2023.34.2.54 · Cited by 2
Continuous glucose monitoring in diabetes
Moe, S. S., Kolber, M. R., & Falk, J. (2023) · Canadian Family Physician · doi:10.46747/cfp.6906406 · Cited by 3
Mark‐Wagstaff, C., Deshmukh, H., Wilmot, E. G., Walker, N., Barnes, D., Parfitt, V. J., Saunders, S., Gregory, R., Choudhary, P., Patmore, J., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15283 · Cited by 3
Self-citationPasyechko, N. V., Naumova, L. V., Krytskyy, T., & Савченко, І. П. (2024) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.19.8.2023.1343 · Cited by 2
Pinés-Corrales, P. J., López-García, M. C., Sanz‐Velasco, A., Moya, A. J. M., Díaz, C. G., & Blasco, L. G. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108723 · Cited by 2
Update on recent advances in technology in type 1 diabetes
Aslam, A., Thabit, H., & Leelarathna, L. (2024) · British Journal of Diabetes · doi:10.15277/bjd.2024.440 · Cited by 3
Self-citationWu, C., Devireddy, R. R., Zazaian, A., Kambhatla, S., Alzohaili, O., & Saad, C. (2024) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000319 · Cited by 2
Kandiyali, R., Taylor, H., Thomas, E., Cullen, F., Hollingworth, W., Ingram, J. C., Kenward, C., West, N., McGregor, D., Smith, B., et al. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003561 · Cited by 2
Newer Outpatient Diabetes Therapies and Technologies
Kamal, N., Lee, K., & Aleppo, G. (2024) · Medical Clinics of North America · doi:10.1016/j.mcna.2024.03.002 · Cited by 2
Zhou, Y., Wheeler, B. J., Boucsein, A., Styles, S. E., Chamberlain, B., Michaels, V. R., Crocket, H. R., Lala, A., Cunningham, V. J., Wiltshire, E. J., et al. (2024) · Diabetic Medicine · doi:10.1111/dme.15494 · Cited by 2
Understanding Continuous Glucose Monitoring
Murray-Bachmann, R., Pendyaia, R., Cichosz, T., Yeung, E., & Fishman, S. L. (2024) · Contemporary Endocrinology · doi:10.1007/978-3-031-75352-7_3 · Cited by 1
Exogenous vs Endogenous Insulin Delivery: 2025
Patel, A., Todd, R., Owen‐Simon, N. L., & McCune, K. R. (2025) · Current Transplantation Reports · doi:10.1007/s40472-025-00468-6 · Cited by 1
Berthoumieux, A., Naqvi, J. B., Zion, S. R., Napoleone, J. M., McGuill, A., Cerrada, C. J., Lee, H. J., Dunn, T. C., Kerr, D. E., Jasik, C. B., et al. (2026) · Journal of Medical Internet Research · doi:10.2196/78321 · Cited by 2
“Can you stop beeping!”: Designing Notifications that Empathise with Fatigue in Diabetes Technology
Telang, S., Barth, C.-M., & Huang, E. M. (2025) · Designing Interactive Systems Conference · doi:10.1145/3715668.3736353 · Cited by 2
Chu, L., & Abitbol, A. (2025) · Diabetic Medicine · doi:10.1111/dme.70119 · Cited by 1
Tan, J. C., Khalil, M. A. M., Avari, P., & Leelarathna, L. (2025) · Frontiers in Nephrology · doi:10.3389/fneph.2025.1630597 · Cited by 1
Self-citationRangel-Osuna, F., Infante-Xibille, C., & Orozco-Núñez, E. (2025) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2025.130 · Cited by 1
Cigler, M., el Hakouni, O., Meçani, R., Pouwer, F., Abbink, E. J., Moser, M., de Galan, B. E., Renard, É., Evans, M. L., Brøsen, J. M. B., et al. (2026) · Diabetic Medicine · doi:10.1111/dme.70301 · Cited by 1
Self-citationIl monitoraggio in continuo della glicemia: stato dell’arte
Irace, C., & Molfetta, S. D. (2022) · il Diabete · doi:10.30682/ildia2204g · Cited by 1
Glycemia control using remote technologies
Суплотова, Л. А., & Alieva, O. O. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-157 · Cited by 1
Ólafsdóttir, A. F., & Lind, M. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1247616 · Cited by 1
An Analysis of the Distribution of Direct Cost of Diabetes Care in Selected Districts in Italy
Mennini, F. S., Sciattella, P., Marcellusi, A., Bartolini, F., Bernardi, F. F., Levrat‐Guillen, F., Cozzolino, M., Gennaro, M. D., Giordana, R., Giustozzi, M., et al. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01580-z · Cited by 1
Dei, A., Aldigeri, R., Bellei, G., Raffaeli, D., Bartolo, P. D., Sforza, A., Marchesini, G., Ciardullo, A. V., Manicardi, V., Bianco, M., et al. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02298-x · Cited by 2
Алимова, И. Л., & Demyanenko, A. N. (2024) · Russian Medicine · doi:10.17816/medjrf629450 · Cited by 1
Sebastián‐Valles, F., Martín, J. A. A., Alfonso, J. M., Jiménez‐Díaz, J., Alday, I. H., Navas-Moreno, V., Joya, T. A., García, M., Gómez, G. L. R., Hierro, J. G., et al. (2024) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70020 · Cited by 1
Liashko, D., Domanskyi, R., Yanitska, L. V., Horkunenko, O., & Yezhel, I. (2025) · Ukrainian Scientific Medical Youth Journal · doi:10.32345/usmyj.1(152).2025.123-129 · Cited by 1
Sebastián‐Valles, F., Alday, I. H., Tapia-Sanchiz, M. S., Raposo‐López, J. J., Hierro, J. G., Navas-Moreno, V., Alfonso, J. M., Martín, J. A. A., Sampedro-Nuñez, M. A., & Marazuela, M. (2025) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2024.10.027 · Cited by 1
Levrat‐Guillen, F., & Cock, P. D. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02427-y · Cited by 1
Ruiz Gracia, T., Nattero-Chávez, L., Arranz Martín, A., de la Calle de la Villa, E., Lorenzo Moñino, M., Bayona Cebada, A., Corral, M. I., Quintero Tobar, A., Lahera Vargas, M., Jiménez Blanco, S., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113505
Protección penal de la intimidad de los usuarios de sistemas informáticos e internet0
Recio, F. G. (2007) · Estudios jurídicos
flash glucose monitoring revolution: the Sat Nav journey
Wilmot, E. G. (2022) · British Journal of Diabetes · doi:10.15277/bjd.2022.372
Self-citationFlash-Monitoring komfortabel und effektiv
Krome, S. (2023) · Diabetologie und Stoffwechsel · doi:10.1055/a-1933-5836
Chien, J., Tsai, Y.-C., Baker, S. W., Gates, K. V., Arbabian, A., & Soh, H. T. (2023) · doi:10.36227/techrxiv.22223335.v1
Chien, J., Tsai, Y.-C., Baker, S. W., Gates, K. V., Arbabian, A., & Soh, H. T. (2023) · doi:10.36227/techrxiv.22223335
Typ-1-Diabetes – neue Aspekte in Therapie und Technologie 2023
Schimmel, T., & Ebert, T. (2023) · Die Diabetologie · doi:10.1007/s11428-023-01061-0
Oliver, N. S. (2023) · Diabetic Medicine · doi:10.1111/dme.15176
Importance of continuous glucose monitoring in the treatment of diabetes mellitus
Moon, S. J., & Lee, W. (2023) · Journal of Korean Medical Association · doi:10.5124/jkma.2023.66.7.432
Editorial: Daily challenges around physical exercise, nutrition and medication in type 1 diabetes
Moser, O., & Dovč, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1259535
Comité de Innovación. Uso de los sistemas de infusión continua de insulina en personas con DM1
Carnero, R., Saleme, A., Lequi, L., Daín, A., Campos, F. S., Sosa, L., Flores, A., & Kabakian, L. (2024) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v58i1sup.763 · Cited by 1
Lameijer, A. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.1021051970
Pérez-López, P. (2024) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/68548
Technologies for Diabetes, volume II
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5453-1
Tecnología aplicada a la diabetes
Cebada, A. B., Silva, J. B. Q., Escobar-Morreale, H. F., & Chávez, L. N. (2024) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2024.10.004
Intermittently scanned continuous glucose monitoring (isCGM) in hospitalized elderly patients
Matvejeva, D., Nováková, M., Piťhová, P., Tománková, L., Kotvová, V., Polanecká, D., & Kvapil, M. (2024) · Vnitřní lékařství · doi:10.36290/vnl.2024.086
Impacto del inicio de la monitorización flash de glucosa en pacientes adultos con diabetes tipo 1
Sahagún, R. J. (2024) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/72390
Value of continuous glucose monitoring in children and adolescents with type 1 diabetes mellitus
Hegazy, D. A. H., Erfan, A. A., Ibrahim, W. S., & Shall, S. I. E. (2025) · Alexandria Journal of Pediatrics · doi:10.4103/ajop.ajop_38_24
Traitement de la rétinopathie diabétique
Massin, P., Dupas, B., Erginay, A., Feldman, S., & Lecleire-Collet, A. (2025) · Elsevier eBooks · doi:10.1016/b978-2-294-78350-0.00008-8
Shestakova, M. V., Peterkova, V. A., Galstyan, G. R., Ibragimova, L. I., Klimontov, V. V., Лаптев, Д. Н., Malaya, I. P., & Shestakova, E. A. (2025) · Diabetes Mellitus · doi:10.14341/dm13329
Insulins, Technologies, and Telemedicine
Cipponeri, E., Vitale, L., Milani, I., & Caruso, R. (2025) · Springer eBooks · doi:10.1007/978-3-032-01700-0_16
Digital Technology in the Management and Prevention of Diabetes, volume II
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-7053-1
Investigating the co-management of diabetes and dementia: a challenging duo.
Sharkey, F., & COATES, V. E. (2024) · Ulster University Research Portal (Ulster University)
Banaś, A., Bigajski, H., Janczarski, S., Kwolek, K., Laskowska, W., Michalik, M., Owczarska, A., Pilarek, M., Sarna, D., & Widera, P. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(48).2025.4457
Więckowska, K., Bruska, N. M., Cemaga, R., Patalong, M., Błaszkowski, B., Czapliński, M., Kołodziej, P., Krol, M. D., Hebda, P., & Bylik, A. (2026) · Quality in Sport · doi:10.12775/qs.2026.51.68744
Batir, D. M., Boev, M., Gurău, G., Matei, M. N., Nechita, A., & Maftei, N.-M. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014475
Why hyperinsulinemia is detrimental to weight loss: insights from type 1 diabetes
Martin, S., Kempf, K., & Kolb, H. (2026) · BMC Medicine · doi:10.1186/s12916-026-04849-1 · Cited by 1
Elmorsy, B. Z., Ghazi, H. A., Nowara, A. S., & Elsherbiny, H. A. (2026) · International Journal of Diabetes and Technology · doi:10.4103/ijdt.ijdt_43_25
Chiku, Y., Hirano, T., Tsuchiya, A., Takahashi, Y., Hoshiyama, K., & Murata, T. (2026) · Scientific Reports · doi:10.1038/s41598-026-53112-3
Gai, B., Chen, W., & Qiu, L. (2026) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2026.10.009
Liarakos, A. L., Randhay, A., Leelarathna, L., Crabtree, T. S. J., Doleman, B., Eldehni, M. T., Selby, N. M., Taal, M. W., Idris, I., & Wilmot, E. G. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70954
Self-citationAita, F. C., Guillén, A. C., González-Rojas, M., Rodríguez, C., Salazar, F. R., & Oviedo, L. U. (2026) · Acta Médica Costarricense · doi:10.51481/amc.v67i4.1481
Roy, N., Powers, M., Gonzalez, M., & Cucullo, L. (2026) · Biosensors · doi:10.3390/bios16090477 · Cited by 1
Pastor, A. G., Pomares, F., & Quesada, J. A. (2026) · Primary care diabetes · doi:10.1016/j.pcd.2026.07.014
Pazmiño, S., Schmid, S., Steenackers, N., Sandig, R., van Laar, A., Weiskorn, J., Meulemeester, J. D., Mader, J. K., Charleer, S., Wosch, F. J., et al. (2026) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2026.101806
Wellens-Mensah, J., Deshmukh, H., Ssemmondo, E., Walton, C., Ryder, R. E. J., Wilmot, E. G., & Sathyapalan, T. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71198
Self-citationGlucose Monitoring: Advances in Technology
McDonnell, D. J., Smith, D., & Forde, H. E. (2026) · Springer eBooks · doi:10.1007/978-3-032-24854-1_4
Modern strategies for management of glycaemia in type 1 diabetes
Choo, A., Evans, M. L., & Neupane, S. (2026) · Medicine · doi:10.1016/j.mpmed.2026.07.004
Self-citationMonteiro, N., Lima, L. P. S., Freitas, J. P. A., MACHADO, M. D. L., Gama, F. G., Silva, V. D. S., Martins, L. M., Lemos, S. D. S. F., Torres, G. L., da Silva, D. G., et al. (2026) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2026.08.187
Blount, S. L., Zicari, A., Eiland, L. A., Knezevich, E. L., Newpher, S., Patel, A., Jones, E. P., Kahkoska, A., Khairat, S., & Jewell, V. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113501
The role of wearable technology in the management of type 1 diabetes
Sehgal, S. (2024) · Otago University Research Archive (University of Otago)
Metadata
- Authors
- Leelarathna, L., Evans, M. L., Neupane, S., Rayman, G., Lumley, S., Cranston, I., Narendran, P., Barnard-Kelly, K., Sutton, C. J., Elliott, R. A., Taxiarchi, V. P., Gkountouras, G., Burns, M., Mubita, W., Kanumilli, N., Camm, M., Thabit, H., & Wilmot, E. G.
- Affiliations
- University of Cambridge (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- From the Diabetes, Endocrinology, and Metabolism Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre (L.L., W.M., N.K., M.C., H.T.), the Division of Diabetes, Endocrinology, and Gastroenterology, Faculty of Biology, Medicine, and Health (L.L., H.T.), and the Centre for Biostatistics (C.J.S., V.P.T.), the Manchester Centre for Health Economics (R.A.E., G.G.), and the Manchester Clinical Trials Unit (C.J.S., M.B.), Division of Population Health, Health Service Research and Primary Care, University of Manchester, Manchester, Wellcome Trust–Medical Research Council Institute of Metabolic Science, National Institute for Health and Care Research Cambridge Biomedical Research Centre, Cambridge University Hospitals and University of Cambridge, Cambridge (M.L.E.), Elsie Bertram Diabetes Centre, Norfolk (S.N.), Norwich University Hospitals NHS Foundation Trust, Norwich (S.N.), the Diabetes and Endocrine Centre, Ipswich Hospital, East Suffolk and N...
- University of Nottingham (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2022-10-20
- Volume
- 387
- Issue
- 16
- Pages
- 1477-1487
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4302023802
- Cited by
- 174
- References
- 26
- Citations by year
- 2026: 23 · 2025: 45 · 2024: 49 · 2023: 49 · 2022: 7
- FWCI
- 27.77
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Repository@Nottingham (University of Nottingham) (acceptedVersion, other-oa)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- Research Explorer (The University of Manchester) (submittedVersion, other-oa)
- Funders
- Diabetes UK (18/0005836)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- intermittently scanned continuous glucose monitoring, type 1 diabetes, HbA1c, glycemic control, hypoglycemia, time in range, patient-reported outcomes, diabetes self-management, glycemic variability, HbA1c reduction, hypoglycemia risk reduction, severe hypoglycemia
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Middle Aged, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.